WHO ICTRP trial
Phase I, II study of neoadjuvant chemotherapy with gemcitabine and…
JPRN-jRCTs021200003 · Japan Primary Registries Network (JPRN) · Recruiting
Key facts
| Trial ID | JPRN-jRCTs021200003 |
|---|---|
| Public title | Phase I, II study of neoadjuvant chemotherapy with gemcitabine and nab-paclitaxel for resectable pancreatic cancer |
| Scientific title | Phase I, II study of neoadjuvant chemotherapy with gemcitabine and nab-paclitaxel for resectable pancreatic cancer - APCS-01 |
| Primary sponsor | Ishido Keinosuke |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Recruiting |
| Study type | Interventional |
| Phase | 1-2 |
| Conditions | pancreatic ductal cancer pancreatic ductal cancer;pancreatic ductal cancer |
| Interventions | preoperative chemotherapy, surgical treatment;preoperative chemotherapy and surgical treatment |
| Registration date | Aug 5, 2020 |
| Target size | 30 |
| Registry page | jrct.niph.go.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: